Zobrazeno 1 - 10
of 15
pro vyhledávání: '"You-shan Zhao"'
Autor:
Yao Zhang, Chao Xiao, Jing Li, Lu-xi Song, You-shan Zhao, Shuang Han, Zhao-wei Li, Cha Guo, Jun-gong Zhao, Chun-kang Chang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Objective: The purpose of this study was to identify the difference between dual energy spectral computed tomography (DECT) and magnetic resonance imaging (MRI) used to detect liver/cardiac iron content in Myelodysplastic syndrome (MDS) patients with
Externí odkaz:
https://doaj.org/article/86a93f6ec74b48e4a48c9d0be1a17543
Autor:
Ying Fang, Juan Guo, Dong Wu, Ling-Yun Wu, Lu-Xi Song, Zheng Zhang, You-Shan Zhao, Chun-Kang Chang
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
Despite the improvements in prognostication of the revised International Prognostic Scoring System (IPSS-R) in myelodysplastic syndrome (MDS), there remain a portion of patients with lower risk (low/intermediate risk, LR) but poor prognostics. This s
Externí odkaz:
https://doaj.org/article/3a5de7c84d2c464981db0f77910353d1
Autor:
Cheng-Ming Fei, Juan Guo, You-Shan Zhao, Si-Da Zhao, Qing-Qing Zhen, Lei Shi, Xiao Li, Chun-Kang Chang
Publikováno v:
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-9 (2018)
Abstract Background Hyaluronan (HA), a major component of the extracellular matrix, has been proven to play a crucial role in tumor progression. However, it remains unknown whether HA exerts any effects in myelodysplastic syndromes (MDS). Methods A t
Externí odkaz:
https://doaj.org/article/6c70d1cd41f5477fb5306b018f8a7cfd
Autor:
Ying, Fang, Juan, Guo, Dong, Wu, Ling-Yun, Wu, Lu-Xi, Song, Zheng, Zhang, You-Shan, Zhao, Chun-Kang, Chang
Publikováno v:
Frontiers in Oncology
Despite the improvements in prognostication of the revised International Prognostic Scoring System (IPSS-R) in myelodysplastic syndrome (MDS), there remain a portion of patients with lower risk (low/intermediate risk, LR) but poor prognostics. This s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f6ce13faa1e0d6e5a3f389413151f2b9
https://pubmed.ncbi.nlm.nih.gov/33520721
https://pubmed.ncbi.nlm.nih.gov/33520721
Publikováno v:
Zhongguo shi yan xue ye xue za zhi. 25(5)
To investigate the inhibitory effect of decitabine (DAC) in various dosages on the proliferention of MDS-RAEB cell line MDS-L and its mechanism.LC-MS/MS method was used to test the blood DAC concentration of 2 groups of MDS patients being treated wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0ba905d88721fc1aab48318915fd5be0
https://pubmed.ncbi.nlm.nih.gov/29070127
https://pubmed.ncbi.nlm.nih.gov/29070127
Autor:
Zheng, Zhang, Qi, He, Ying, Tao, Juan, Guo, Feng, Xu, Ling-Yun, Wu, You-Shan, Zhao, Dong, Wu, Li-Yu, Zhou, Ji-Ying, Su, Lu-Xi, Song, Chao, Xiao, Xiao, Li, Chun-Kang, Chang
Publikováno v:
American journal of translational research. 9(2)
Decitabine treatment improves immunological recognition that increases expression of cancer-testis antigens (CTAs) against solid tumors. The mechanisms of decitabine enhancement of immunogenicity when used for patients with myelodysplastic syndromes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::22417e2094d70b6dbed4f5c4b5a8f8d6
https://pubmed.ncbi.nlm.nih.gov/28337274
https://pubmed.ncbi.nlm.nih.gov/28337274
Publikováno v:
Zhongguo shi yan xue ye xue za zhi. 23(3)
To investigate the osteogenic differentiation potential of bone marrow mesenchymal stem cells (BMMSC) in patients with myelodysplastic syndromes (MDS) and to explore the role of BMMSC osteogenic differentiation in the pathogenesis of MDS.BMMSC were i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::be788ca610e6d1fbcbb2e22ad195d085
https://pubmed.ncbi.nlm.nih.gov/26117031
https://pubmed.ncbi.nlm.nih.gov/26117031
Publikováno v:
Zhongguo shi yan xue ye xue za zhi. 22(6)
This study was aimed to investigated the mRNA expression levels of Notch ligands- Delta-like-1 and Jagged-1 in bone marrow mesenchymal stem cells of patients with myelodysplastic syndrome (MDS), and to explore their relation with onset of MDS. Bone m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3454a11d8cef8374a9124e978fe5a674
https://pubmed.ncbi.nlm.nih.gov/25543492
https://pubmed.ncbi.nlm.nih.gov/25543492
Autor:
You-shan, Zhao, Rui, Yang, Shu-cheng, Gu, Juan, Guo, Xi, Zhang, Ling-yun, Wu, Xiao, Li, Chun-kang, Chang
Publikováno v:
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi. 33(10)
To study the methylation status of p73 gene promoter in patients with myelodysplastic syndrome (MDS) and explore its significance with clinical prognosis.Methylation of p73 promoter was detected in bone marrow cells from 135 MDS patients and 13 healt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::55f2e3069b6bec145b9c11b9453632f4
https://pubmed.ncbi.nlm.nih.gov/23384909
https://pubmed.ncbi.nlm.nih.gov/23384909
Publikováno v:
Zhongguo shi yan xue ye xue za zhi. 20(5)
The purpose of this study was to investigate the effect of bisphosphonate combined with chemotherapy on bone mineral density (BMD) of patients with multiple myeloma (MM) and analyse its value of BMD detection in clinic of these patients. 53 MM cases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2ea2a755980aa9f4d3b3ec97b8e008ba
https://pubmed.ncbi.nlm.nih.gov/23114134
https://pubmed.ncbi.nlm.nih.gov/23114134